Cigna's Pivot to Evernorth and the De-Risked Commercial Employer Focus
The Cigna Group's (CI) Q1 2026 earnings highlight a unique strategic divergence from its managed care peers: an active retreat from volatile, government-subsidized health programs in favor of a commercial employer benefits and high-margin services platform.
During the Q1 2026 earnings call, which marked David Cordani's final sign-off as CEO after 70 consecutive quarters before handing reins to Brian Evanko, Cigna reported revenue of $68.49 billion and net income of $1.65 billion. Cigna Healthcare's Medical Care Ratio (MCR) came in at an exceptional 79.8%, beating guidance that had implied a ratio of just under 81%.
The core of Cigna's strategy is the systematic removal of government policy risk from its balance sheet. This started with the sale of its 600,000-member Medicare Advantage business to HCSC in Q1 2025. In Q1 2026, Cigna went a step further, announcing its intention to completely exit the ACA Individual Exchange market by the end of 2026. This exit allows Cigna to avoid the margin pressure and adverse selection currently impacting the individual exchange market following the expiration of enhanced federal tax credits.
Instead of chasing government programs, Cigna is focusing its capital on Evernorth Health Services (which houses its massive Express Scripts PBM and specialty pharmacy business) and its U.S. commercial employer business. By building out a services-oriented platform, Cigna has insulated itself from CMS rate cuts and Medicaid contractions, positioning itself as a corporate benefits manager with strong pricing power and highly predictable commercial margins.